Global pharmaceutical company Allergan has announced key future growth drivers for its medical aesthetics portfolio at its first ever Medical Aesthetics Analyst Day this month.
The Royal College of Surgeons (RCS) and the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) have expressed concerns that health and beauty retailer Superdrug is now offering in-store injectable treatments.
Superdrug has launched the Skin Renew Service, which will provide anti-wrinkle and skin rejuvenation injectable treatments.
Cosmetic Digital is set to launch a range of courses under new company, Th13teen Training.
Global pharmaceutical company Allergan has announced that Botox Cosmetic (onabotulinumtoxinA) has been approved by the US Food and Drug Administration for its third indication.
Aesthetic product supplier 4T Medical is offering two new training courses for botulinum toxin and dermal filler treatments.
Brent Saunders, the CEO of global pharmaceutical company Allergan, has issued a statement asking aesthetic professionals to join a discussion on how the specialty can support teenagers seeking aesthetic treatments.
The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released the results of a survey where 31% of respondents reported being 'extremely likely' to consider a cosmetic procedure, either surgical or non-surgical.
Allergan has reported a total net revenue of $3.6 billion in its continuing operations performance for the first quarter of 2017.
Global pharmaceutical company Allergan has announced plans to invest more than €42 million (over £36 million) in an expansion.